Live Breaking News & Updates on Forte Biosciences

Stay updated with breaking news from Forte biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Large Growth in Short Interest

Forte Biosciences, Inc. (NASDAQ:FBRX – Get Rating) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 116,400 shares, a growth of 203.9% from the March 31st total of 38,300 shares. Based on an average daily volume of 68,000 shares, the […] ....

Forte Biosciences , Renaissance Technologies , Millennium Management , Vanguard Group Inc , Capital Management , Forte Biosciences Inc , Get Rating , Biosciences Trading Down , Forte Biosciences Daily , Nasdaq Fbrx ,

Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX)

Forte Biosciences, Inc. (NASDAQ:FBRX – Get Rating) was the recipient of unusually large options trading on Wednesday. Investors bought 30,205 call options on the company. This represents an increase of 1,663% compared to the typical volume of 1,713 call options. Forte Biosciences Stock Performance Shares of Forte Biosciences stock remained flat at $1.06 during trading […] ....

Forte Biosciences , Capital Management , Millennium Management , Renaissance Technologies , Forte Biosciences Company Profile , Forte Biosciences Inc , Vanguard Group Inc , Get Rating , Forte Biosciences Daily , Nasdaq Fbrx ,

Traders Buy High Volume of Suncor Energy Put Options (NYSE:SU)

Should You Buy or Sell Forte Biosciences Stock? Get The Latest FBRX Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. ....

Forte Biosciences , Vanguard Group Inc , Forte Biosciences Inc , Forte Biosciences Company Profile , Renaissance Technologies , Millennium Management , Capital Management , Get Rating , Forte Biosciences Daily ,

MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting

Presents Highly Qualified Slate of Director Nominees, Including Five Incumbent Board Members and New Independent Candidate David W. GryskaHighlights Significant Positive Momentum to Advance R&D Pipeline and Enhance Shareholder ValueDiscloses FCM MM HOLDINGS’ Intent to Take Control of the Board Through Nomination of. ....

Suzanne Bruhn , Dave Gryska , Carol Vallone , Carola Vallone , Bristol Myers Squibb , Michael Verrechia Eric Kamback , Robert Barrow , Jake Freeman , Davidw Gryska , Dan Zacchei Joe Germani , Andreas Krebs , Scott Freeman , Exchange Commission , Forte Biosciences Inc , Company Or Mindmed , Medicine Mindmed Inc , Seagen Inc , Aerie Pharmaceuticals , Gw Pharmaceuticals , Celgene Corporation , Jazz Pharmaceuticals , Incyte Corporation , Hoskin Harcourt , Company Annual Report On Form , Celgene Corp , Company Board Of Directors The ,